MYC targets and E2F targets-related pathways were also enriched in L-SCLC, while neuroactive ligand-receptor interaction and KRAS signaling pathways were enriched in LCC/LCNEC (Fig. 2D). The gene discussed is MYC; the disease is leukoencephalopathy with calcifications and cysts.